tirzepatide dangers reddit June 8, 2026: Reckless physicians prescribing experimental, black market weight loss drugs: “Why are we waiting?” – Partnership for Safe Medicines Rybelsus, Mounjaro, Wegovy: India's weight-loss
Description
Retatrutide cons Still in clinical trials : Retatrutide is not approved yet and is still in trials so its not commercially available for general use
Tirzepatide activates both GIP and GLP-1 receptors (dual agonist), while semaglutide only targets GLP-1
Usually, once your weight stabilizes, this side effect will subside and your hair will regrow to its original thickness before you started treatment
Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin
